Catherine Schulte

Stock Analyst at Baird

(1.66)
# 1401
Out of 5,344 analysts
139
Total ratings
50.00%
Success rate
5.91%
Average return
18 Stocks
Name Action PT Current % Upside Ratings Updated
A Agilent Technologies
Maintains: Outperform
159 140
108.54 28.98% 16 May 22, 2025
MRVI Maravai LifeSciences
Maintains: Neutral
3 2
2.23 -10.31% 6 May 13, 2025
EXAS Exact Sciences
Maintains: Outperform
69 72
56.76 26.85% 14 May 2, 2025
AVTR Avantor
Maintains: Outperform
21 17
12.66 34.28% 11 Apr 28, 2025
TMO Thermo Fisher Scient...
Maintains: Outperform
603 573
394.4 45.28% 26 Apr 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
231 225
185.23 21.47% 8 Apr 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
1369 1034
1112.36 -7.04% 8 Apr 22, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
42 43
42.01 2.36% 4 Apr 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
88 68
46.75 45.45% 9 Feb 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
182 165
n/a n/a 6 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
42 38
16.02 137.2% 7 Mar 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
56 33
28.36 16.36% 3 Nov 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
4 2
n/a n/a 1 Jun 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
335 281
80 251.25% 6 Sep 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
21
n/a n/a 1 May 26, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
35 29
n/a n/a 5 Apr 7, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
208 217
344 -36.92% 7 Oct 30, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
17 20
153.53 -86.97% 1 Jun 28, 2018